What is Leerink Partnrs’ Estimate for INSP FY2028 Earnings?

Inspire Medical Systems, Inc. (NYSE:INSP) – Investment analysts at Leerink Partnrs reduced their FY2028 earnings per share estimates for shares of Inspire Medical Systems in a report released on Tuesday, February 11th. Leerink Partnrs analyst M. Kratky now expects that the company will post earnings per share of $5.62 for the year, down from their prior estimate of $5.69. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $1.33 per share.

A number of other equities research analysts also recently commented on INSP. Morgan Stanley cut their target price on shares of Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating for the company in a research report on Tuesday. Truist Financial dropped their price target on Inspire Medical Systems from $250.00 to $235.00 and set a “buy” rating on the stock in a research note on Tuesday. Bank of America upgraded Inspire Medical Systems from a “neutral” rating to a “buy” rating and upped their price objective for the company from $220.00 to $255.00 in a research report on Wednesday, November 20th. Robert W. Baird cut their price target on Inspire Medical Systems from $252.00 to $248.00 and set an “outperform” rating for the company in a research note on Tuesday. Finally, KeyCorp reaffirmed an “overweight” rating and set a $234.00 price target (down previously from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $228.82.

Inspire Medical Systems Stock Up 1.2 %

Shares of INSP stock opened at $183.17 on Wednesday. The company has a 50 day moving average price of $189.39 and a 200-day moving average price of $191.39. Inspire Medical Systems has a 52 week low of $123.00 and a 52 week high of $257.40. The firm has a market capitalization of $5.49 billion, a PE ratio of 171.18 and a beta of 1.32.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings data on Monday, February 10th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. WINTON GROUP Ltd increased its stake in Inspire Medical Systems by 15.6% in the 4th quarter. WINTON GROUP Ltd now owns 5,977 shares of the company’s stock worth $1,108,000 after buying an additional 806 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Inspire Medical Systems by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 3,270,357 shares of the company’s stock worth $606,259,000 after acquiring an additional 38,219 shares during the period. KLP Kapitalforvaltning AS purchased a new stake in shares of Inspire Medical Systems during the fourth quarter worth about $1,186,000. Sei Investments Co. grew its position in shares of Inspire Medical Systems by 27.7% during the fourth quarter. Sei Investments Co. now owns 163,474 shares of the company’s stock worth $30,305,000 after purchasing an additional 35,486 shares in the last quarter. Finally, American Century Companies Inc. lifted its holdings in Inspire Medical Systems by 66.9% in the 4th quarter. American Century Companies Inc. now owns 11,214 shares of the company’s stock worth $2,079,000 after purchasing an additional 4,497 shares in the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.